SYNLOGIC, INC. (SYBX) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US87166L1008
Price
1.10 USD
Market cap
13.54 m USD
P/E (2026)
–
P/S (2026)
–
Dividend yield
0.00 %
Net margin
–
Return on equity (ROE)
–
Return on assets (ROA)
–
SYNLOGIC, INC. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 0.00 USD |
| Operating income | -4.01 m USD |
| EBIT | -1.01 m USD |
| Net income | -1.01 m USD |
| Diluted EPS – continuing operations | -0.08 USD |
Full history since 2011, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About SYNLOGIC, INC.
Synlogic, Inc. does not have significant operations. It was previously engaged in the discovery and development of synthetic biotics to treat metabolic diseases. Synlogic, Inc. is based in Winchester, Massachusetts.
More stocks
- AIR INDUSTRIES GROUP (AIRI)
- BLOOMIA HOLDINGS, INC. (TULP)
- Linkhome Holdings Inc. (LHAI)
- Awaysis Capital, Inc. (AWCA)
- Dolphin Entertainment, Inc. (DLPN)
- Super League Enterprise, Inc. (SLE)
- KIDOZ INC. (KDOZF)
- PARKERVISION INC (PRKR)
- BioCardia, Inc. (BCDA)
- PCS Edventures!, Inc. (PCSV)
- SPAR Group, Inc. (SGRP)
- TAITRON COMPONENTS INC (TAIT)
Not investment advice. All data without warranty, price as of 16.11.2026. Details in the risk notice.